FDA orphan drug designation: treatment of acute lymphoblastic leukemia
All entries for: Shenzhen Pregene Biopharma Co. Ltd.
August 19, 2025
Shenzhen Pregene Biopharma Co. Ltd.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of acute lymphoblastic leukemia
